DRD1 Gene

Migration, Crosslink

📖

DRD1 Gene

active

wiki page Created: 2026-04-02T07:19:20 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-genes-drd1

📖 Wiki Page

gene1227 wordssynced 2026-04-02

DRD1 Gene

Pathway Diagram

flowchart TD DRD1["DRD1 Gene"] %% Dopamine signaling DA["Dopamine Signaling"] cAMP["cAMP Pathway"] %% Inflammatory processes INFLAM["Inflammation"] NEUROINFLAM["Neuroinflammation"] %% Major neurodegenerative diseases PD["Parkinson Disease"] HD["Huntington Disease"] AD["Alzheimer Disease"] ALS["Amyotrophic Lateral Sclerosis"] MS["Multiple Sclerosis"] %% Psychiatric conditions SCZ["Schizophrenia"] BP["Bipolar Disorder"] DEP["Depression"] %% Other conditions SYN["Synucleinopathy"] AUTISM["Autism"] %% Connections DRD1 -->|"encodes receptor"| DA DA -->|"activates"| cAMP DRD1 -->|"regulates"| INFLAM DRD1 -->|"activates"| NEUROINFLAM DRD1 -->|"associated with"| PD DRD1 -->|"expressed in"| HD DRD1 -->|"therapeutic target"| AD DRD1 -->|"therapeutic target"| ALS DRD1 -->|"therapeutic target"| MS DRD1 -->|"associated with"| SCZ DRD1 -->|"associated with"| BP DRD1 -->|"associated with"| DEP DRD1 -->|"associated with"| SYN DRD1 -->|"associated with"| AUTISM NEUROINFLAM -->|"contributes to"| PD NEUROINFLAM -->|"contributes to"| AD style DRD1 fill:#006494,color:#e0e0e0 style DA fill:#4a1a6b,color:#e0e0e0 style cAMP fill:#4a1a6b,color:#e0e0e0 style INFLAM fill:#ef5350,color:#0d0d1a style NEUROINFLAM fill:#ef5350,color:#0d0d1a style PD fill:#ef5350,color:#0d0d1a style HD fill:#ef5350,color:#0d0d1a style AD fill:#ef5350,color:#0d0d1a style ALS fill:#ef5350,color:#0d0d1a style MS fill:#ef5350,color:#0d0d1a

...

DRD1 Gene

Pathway Diagram

Mermaid diagram (expand to render)

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">DRD1 — Dopamine Receptor D1</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>DRD1</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Dopamine Receptor D1</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>5q35.2</td>
</tr>
<tr>
<td class="label">NCBI Gene</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/1817" target="_blank">1817</a></td>
</tr>
<tr>
<td class="label">Ensembl</td>
<td><a href="https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000184845" target="_blank">ENSG00000184845</a></td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/P21709" target="_blank">P21709</a></td>
</tr>
<tr>
<td class="label">Diseases</td>
<td>[Parkinson's Disease](/diseases/parkinsons-disease), [Schizophrenia](/diseases/schizophrenia), [Huntington's Disease](/diseases/huntingtons)</td>
</tr>
<tr>
<td class="label">Expression</td>
<td>Striatum, Cortex, Nucleus accumbens, Olfactory bulb</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">Alzheimer</a>, <a href="/wiki/bipolar" style="color:#ef9a9a">Bipolar</a>, <a href="/wiki/depression" style="color:#ef9a9a">Depression</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">132 edges</a></td>
</tr>
</table>

DRD1 — Dopamine Receptor D1

Introduction

Drd1 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

DRD1 (Dopamine Receptor D1) encodes the D1 dopamine receptor, a G protein-coupled receptor that stimulates adenylyl cyclase and increases intracellular cAMP. It is the most abundant dopamine receptor in the striatum and plays critical roles in motor control, reward, and cognition[@missale1998].

Function

The D1 receptor is a postsynaptic dopamine receptor that:

Signaling Pathways

Gs/olf coupling: Activates adenylyl cyclase → increases cAMP
PKA activation: Phosphorylates DARPP-32 and other targets
Gene transcription: Modulates CREB-mediated transcription
ERK/MAPK activation: Downstream signaling cascades
Beta-arrestin pathways: G protein-independent signaling

Brain Functions

Motor control: Direct pathway activation in basal ganglia[@drd1_striatum]
Reward processing: Mediates dopamine's rewarding effects[@drd1_addiction]
Cognition: Working memory and attention[@drd1_cognition]
Motor learning: Habit formation and procedural memory
Endocrine regulation: Modulates prolactin secretion

Molecular Interactions

The D1 receptor interacts with multiple proteins:

G proteins: Gs, Golf (striatum-specific)

DARPP-32: Phosphoprotein that amplifies D1 signaling

AKAP79: Anchors PKA to the membrane

beta-arrestin 2: Mediates desensitization and alternative signaling

NMDA receptors: Regulation of glutamatergic transmission

Disease Associations

Parkinson's Disease

DRD1 agonists used therapeutically
Loss of D1-expressing [neurons](/entities/neurons) in PD
D1 dysfunction contributes to akinesia

Schizophrenia

D1 hypofunction theory of cognitive deficits
D1 agonists may improve working memory
Interactions with antipsychotic drugs

Huntington's Disease

Early loss of D1 receptors
Contributes to chorea and cognitive deficits
D1 agonists being explored therapeutically

Alzheimer's Disease

D1 receptors modulate hippocampal plasticity
Potential role in memory consolidation
Interactions with amyloid pathology
Cognitive effects of D1 modulation

Neurodegeneration Mechanisms

Excitotoxicity

D1-mediated cAMP can increase neuronal energy demands
Potential for excitotoxic vulnerability in PD
Interactions with glutamatergic signaling

Oxidative Stress

Dopamine metabolism produces ROS
D1 signaling may modulate antioxidant responses
Vulnerability of D1 neurons in PD

Neuroinflammation

D1 receptors on microglia regulate inflammation
Anti-inflammatory effects of D1 activation
Implications for PD and AD pathogenesis

Therapeutic Targeting

| Drug Class | Examples | Indication |
|------------|----------|------------|
| D1 agonists | Aplindore, PF-06412562 | PD, Restless legs |
| D1 partial agonists | Sumarampion | Potential cognitive enhancer |

Therapeutic Targeting

Parkinson's Disease

D1 agonists: rotate to D1-selective agents under development
combination therapy with D2 agonists
Deep brain stimulation affects D1-expressing neurons

Neuropsychiatric Disorders

A71113 being investigated for cognitive enhancement
D1 agonists for working memory deficits in schizophrenia
Potential for dystonia treatment

Molecular Mechanism

Gs Coupling

Activates adenylyl cyclase
Increases cAMP
Activates PKA
Phosphorylates DARPP-32 (enhances D2 inhibition)

Beta-Arrestin Signaling

D1 can signal through beta-arrestin pathways
G protein-independent signaling
Role in D1-mediated behaviors

Neuronal Expression

Highest in striatum (direct pathway neurons)
[Cortex](/brain-regions/cortex) (layer V pyramidal neurons)
[Hippocampus](/brain-regions/hippocampus)
Substantia nigra pars reticulata
Olfactory bulb

Protein Structure and Pharmacology

Receptor Structure

Seven transmembrane domain GPCR
Extracellular N-terminus for ligand binding
Intracellular C-terminus for G protein coupling
Conserved DRY motif for G protein activation

Ligand Binding

Endogenous ligand: dopamine
Agonists: higher efficacy at D1
Antagonists: typical antipsychotics
Partial agonists: some experimental compounds

Genetic Studies

Parkinson's Disease

DRD1 polymorphisms not strongly associated with PD risk
Haplotypes may influence drug response
Interaction with other PD risk genes

ADHD

DRD1 associations with attention deficit hyperactivity disorder
Pharmacogenetic considerations for stimulant therapy

Tourette Syndrome

D1 antagonists reduce tics
Direct pathway hyperactivity model
Deep brain stimulation targeting D1 neurons

Clinical Considerations

Therapeutic Implications

D1 agonists for Parkinson's disease motor symptoms
Potential for cognitive enhancement
Dyskinesia management strategies
Combination with D2 therapies

Biomarkers

D1 receptor density imaging (PET)
Gene expression studies
CSF biomarkers

Animal Models

Knockout Studies

Drd1 knockout mice show reduced locomotor activity
Impaired reward learning
Learning and memory deficits

Transgenic Models

D1 overexpression: enhanced locomotion
Constitutively active D1: hyperactive behaviors
Cre driver lines for conditional deletion

Disease Models

6-OHDA lesion: D1 expression changes
MPTP model: D1 dysfunction
Transgenic AD models: D1 interactions

Research Directions

Emerging Areas

D1-selective agonists with better pharmacokinetics

Allosteric modulators for subtype specificity

biased signaling - G protein vs beta-arrestin

PET ligands for D1 imaging

Key Unanswered Questions

How does D1 signaling differ in aging vs PD?
Can D1 modulators slow neurodegeneration?
What determines individual drug response?
How do D1/D2 interactions affect circuit function?

Basal Ganglia Circuitry

Direct Pathway (Movement)

The direct pathway is the "go" pathway:

Cortex sends excitatory projections to striatum

D1-expressing striatal neurons (direct pathway) receive this input

These neurons project to substantia nigra pars reticulata (SNr) and GPi

Direct pathway activation inhibits SNr/GPi, reducing thalamic inhibition

This facilitates movement initiation and execution

Indirect Pathway (Braking)

The indirect pathway involves D2 receptors:

Cortex excites striatal D2 neurons

D2 neurons project to external globus pallidus (GPe)

GPe inhibits subthalamic nucleus (STN)

STN excites SNr/GPi

This pathway inhibits movement

D1 in Network Context

D1 neurons receive input from sensorimotor cortex
D1 and D2 neurons are intermingled in striatum
D1 neurons have longer dendritic spines (接收更多兴奋性输入)
D1 signaling enhances signal-to-noise in direct pathway

References

[Parkinson's Disease](/diseases/parkinsons-disease)
[Dopamine Signaling](/mechanisms/dopamine-signaling)
[Striatum](/brain-regions/striatum)
[Basal Ganglia](/brain-regions/basal-ganglia)
[DRD2](/proteins/drd2-protein)

External Links

[NCBI Gene: DRD1](https://www.ncbi.nlm.nih.gov/gene/1817)
[UniProt: DRD1](https://www.uniprot.org/uniprot/P21709)
[IUPHAR: DRD1](https://www.guidetopharmacology.org/GTOF/g137)

Background

The study of Drd1 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

Brain Atlas Resources

Allen Human Brain Atlas: [DRD1 expression search](https://human.brain-map.org/microarray/search/show?search_term=DRD1)
Allen Mouse Brain Atlas: [DRD1 search](https://mouse.brain-map.org/search/index.html?query=DRD1)
Allen Cell Type Atlas: [Transcriptomic cell type reference](https://portal.brain-map.org/atlases-and-data/rnaseq)
BrainSpan Developmental Transcriptome: [DRD1 developmental expression](https://www.brainspan.org/rnaseq/search/index.html?search_term=DRD1)

References

[Missale C, Nash SR, Robinson SW, et al, Dopamine receptors: from structure to function (1998)](https://pubmed.ncbi.nlm.nih.gov/9457173/)

[Beaulieu JM, Gainetdinov RR, The physiology, signaling, and pharmacology of dopamine receptors (2011)](https://pubmed.ncbi.nlm.nih.gov/21303898/)

[Gerfen CR, et al, D1 and D2 dopamine receptor-regulated gene expression in the striatum (1995)](https://pubmed.ncbi.nlm.nih.gov/7530793/)

[Surmeier DJ, et al, Dopamine receptor plasticity in Parkinson's disease (2012)](https://pubmed.ncbi.nlm.nih.gov/22713599/)

[Kalia LV, Lang AE, Parkinson's disease (2015)](https://pubmed.ncbi.nlm.nih.gov/25904081/)

[D1 dopamine receptor regulation of striatal function (PMID:19773756)](https://pubmed.ncbi.nlm.nih.gov/19773756/)

[D1 dopamine receptors in basal ganglia circuits (PMID:22462580)](https://pubmed.ncbi.nlm.nih.gov/22462580/)

[D1 dopamine receptor and working memory in prefrontal cortex (PMID:18585467)](https://pubmed.ncbi.nlm.nih.gov/18585467/)

[D1 dopamine receptor in addiction and reward learning (PMID:29104134)](https://pubmed.ncbi.nlm.nih.gov/29104134/)

[Levodopa-induced dyskinesia and D1 receptor signaling (PMID:30352823)](https://pubmed.ncbi.nlm.nih.gov/30352823/)

[D1 dopamine receptor neuroprotection in Parkinson's disease models (PMID:28592752)](https://pubmed.ncbi.nlm.nih.gov/28592752/)

Pathway Diagram

The following diagram shows the key molecular relationships involving DRD1 Gene discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

📖 View canonical wiki page →

Related Entities

DRD1

▸Metadataorigin_type: v1_polymorphic_backfill

slug	genes-drd1
kg_node_id	DRD1
entity_type	gene
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-6953fa982c07
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'genes-drd1'}
_schema_version	1

📊 Evidence Profile Foundational

Evidence Balance

+0%

Certainty

100%

Debates

0

Incoming

37

Outgoing

43

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

DRD1 Gene

DRD1 Gene

Pathway Diagram

DRD1 Gene

Pathway Diagram

DRD1 — Dopamine Receptor D1

Introduction

Overview

Function

Signaling Pathways

Brain Functions

Molecular Interactions

Disease Associations

Parkinson's Disease

Schizophrenia

Huntington's Disease

Alzheimer's Disease

Neurodegeneration Mechanisms

Excitotoxicity

Oxidative Stress

Neuroinflammation

Therapeutic Targeting

Therapeutic Targeting

Parkinson's Disease

Neuropsychiatric Disorders

Molecular Mechanism

Gs Coupling

Beta-Arrestin Signaling

Neuronal Expression

Protein Structure and Pharmacology

Receptor Structure

Ligand Binding

Genetic Studies

Parkinson's Disease

ADHD

Tourette Syndrome

Clinical Considerations

Therapeutic Implications

Biomarkers

Animal Models

Knockout Studies

Transgenic Models

Disease Models

Research Directions

Emerging Areas

Key Unanswered Questions

Basal Ganglia Circuitry

Direct Pathway (Movement)

Indirect Pathway (Braking)

D1 in Network Context

References

External Links

Background

Brain Atlas Resources

References

Pathway Diagram

💬 Discussion